性行为感染传染病诊断检测市场（按检测类型和地区）

性行为感染传染病诊断检测市场规模预计在 2025 年达到 124.9 亿美元，预计到 2032 年将达到 237.3 亿美元，2025 年至 2032 年的复合年增长率为 9.6%。

性行为感染传染病 (STD) 是透过性接触在人与人之间传播的疾病。及早发现和诊断性传染病可以防止进一步感染。实验室检查可以透过血液检查、尿液检体、腰椎穿刺和体液检体确定病因并发现合併感染疾病。对无症状族群进行疾病检测称为筛检。筛检可以针对多种感染疾病进行，包括爱滋病毒、B型肝炎、披衣菌感染、梅毒、淋病和C型肝炎。性行为感染的治疗方法是使用抗生素和抗病毒药物，以防止疾病进一步传播。

市场动态

性行为感染）的盛行率不断上升，政府对性行为感染治疗和管理的投入预计将推动全球性行为感染诊断检测市场的成长。例如，2023年2月2日，印度生物技术公司Mylab Discovery Solutions Pvt. Ltd.推出了针对性传播感染（ 性行为感染）的快速检测套组，包括人类免疫力缺乏病毒（HIV）、C型肝炎病毒（HCV）和梅毒。在这些检测中，HIV 1/2 Ab和HCV Ab是分别检测HIV-1、HIV-2和HCV特异性抗体的快速检测，而梅毒抗体检测则是检测有助于诊断梅毒的抗体（IgG、IgA和IgM）。

研究的主要特点

• 本报告对全球性行为感染诊断检测市场进行了详细分析，并以 2024 年为基准年，提供了预测期 2025-2032 的市场规模（十亿美元）和年复合成长率（CAGR）。
• 它还强调了各个领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
• 它根据公司亮点、产品系列、关键亮点、绩效和策略等参数，介绍了全球性行为感染传染病诊断测试市场的主要企业概况。
• 研究涉及的主要企业包括 Vela Diagnostics USA Inc.、Roche Holdings AG、Alere, Inc.、Becton Dickinson & Company、bioMerieux、Danaher Corporation (Beckman Coulter)、Hologic, Inc.、binx health、Chembio Diagnostics、Pinpoint Science Inc. 和 bioLytical Laboratories。
• 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
• 全球性行为感染诊断测试市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员可以透过全球性行为感染诊断测试市场分析中使用的各种策略矩阵来促进决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• 一致的机会图（COM）

第三章市场动态、法规与趋势分析

• 市场动态
  • 驱动程式
  • 限制因素
  • 市场机会
• 影响分析
• 最新产品发布
• 流行病学
• 合併、收购与合作
• 监管情景
• PEST分析

4. 2020 年至 2032 年全球性行为感染传染病诊断检测市场（依检测类型）

• 介绍
• 披衣菌感染
• 淋病
• 梅毒
• HIV
• HPV阳性的子宫颈抹片
• HSV
• 软性下疳

5. 2020 年至 2032 年全球性行为感染传染病诊断检测市场（按地区）

• 介绍
• 北美洲
  • 美国
  • 加拿大
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
• 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 东南亚国协
  • 澳洲
  • 韩国
  • 其他亚太地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
• 非洲
  • 北非
  • 中部非洲
  • 南非

第六章 竞争态势

• Vela Diagnostics USA Inc.
• Roche Holdings AG
• Alere, Inc.
• Becton Dickinson & Company
• bioMerieux
• Danaher Corporation（Beckman Coulter）
• Hologic, Inc.
• binx health
• Chembio Diagnostics
• Pinpoint Science Inc.
• bioLytical Laboratories

第 7 章 章节

• 调查方法
• 关于出版商

Diagnostic Testing Of Stds Market is estimated to be valued at USD 12.49 Bn in 2025 and is expected to reach USD 23.73 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.6% from 2025 to 2032.

Sexually Transmitted Diseases (STDs) are diseases that spread from person-to-person through sexual contact. Early identification or diagnosis of STDs can help stop further transmission. Laboratory tests can identify the cause and detect co-infections through blood tests, urine samples, swab tests, lumbar puncture, and fluids samples. Testing for a disease in someone who doesn't have symptoms is called screening. The screening can be done for a variety of infections like HIV, hepatitis B, chlamydia, syphilis, gonorrhea, and hepatitis C. Cervical cancer is often caused by certain strains of HPV. Treatment of STDs can be done by antibiotics and antiviral drugs which prevents the further spread of disease.

Market Dynamics

The increasing prevalence of STDs, government fundings for the treatment and management of STDs is expected to drive the global diagnostic testing of STDs market growth. For instance, on February 2, 2023, Mylab Discovery Solutions Pvt. Ltd., an India-based biotechnology company, launched rapid test kits for sexually transmitted diseases including human immunodeficiency virus (HIV), Hepatitis C virus (HCV), and syphilis. Among these tests, HIV 1/2 Ab, and HCV Ab are rapid tests for the detection of antibodies specific to HIV-1, HIV-2, and HCV respectively, while the syphilis antibody test detects antibodies (IgG, IgA, and IgM) to aid in the diagnosis of syphilis.

Key features of the study

• This report provides an in-depth analysis of the global diagnostic testing of STDs market and provides market size (USD Bn) and Compound Annual Growth Rate (CAGR) for the forecast period 2025-2032, considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global diagnostic testing of STDs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• The key companies covered as a part of this study include Vela Diagnostics USA Inc., Roche Holdings AG, Alere, Inc., Becton Dickinson & Company, bioMerieux, Danaher Corporation (Beckman Coulter), Hologic, Inc., binx health, Chembio Diagnostics, Pinpoint Science Inc., and bioLytical Laboratories.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type upgrade, market expansion, and marketing tactics.
• The global diagnostic testing of STDs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diagnostic testing of STDs market.

Market Segmentation

• Global Diagnostic Testing of STDs Market, By Test Type
  • Chlamydia
  • Gonorrhea
  • Syphilis
  • HIV
  • HPV+pap smear
  • HSV
  • Chancroid
• Global Diagnostic Testing of STDs Market, By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • North Africa
  • Central Africa
  • South Africa
• Company Profiles
  • Vela Diagnostics USA Inc.
  • Roche Holdings AG
  • Alere, Inc.
  • Becton Dickinson & Company
  • bioMerieux
  • Danaher Corporation (Beckman Coulter)
  • Hologic, Inc.
  • binx health
  • Chembio Diagnostics
  • Pinpoint Science Inc.
  • bioLytical Laboratories.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Test Type
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trend Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Recent Product Launches
• Epidemiology
• Merger, Acquisition, and Collaborations
• Regulatory Scenario
• Key Developments
• PEST Analysis

4. Global Diagnostic Testing of STDs Market, By Test Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Chlamydia
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Gonorrhea
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Syphilis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• HIV
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• HPV+ pap smear
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• HSV
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Chancroid
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Diagnostic Testing of STDs Market, By Region, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020-2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

6. Competitive Landscape

• Vela Diagnostics USA Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Roche Holdings AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Alere, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Becton Dickinson & Company
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• bioMerieux
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Danaher Corporation (Beckman Coulter)
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Hologic, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• binx health
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Chembio Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Pinpoint Science Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• bioLytical Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

7. Section

• Research Methodology
• About Us